PREDICT研究识别与肝硬化急性失代偿临床病程相关的诱发事件
PREDICT多中心前瞻性观察研究纳入1,273例非择期住院的肝硬化急性失代偿(AD)患者(无ACLF 1,071例,ACLF 202例),分析诱发事件特征及其与结局的关系。结果显示,证实的细菌感染和严重酒精性肝炎(单独或联合)占AD-No ACLF和AD-ACLF队列中有诱发事件患者的96%和97%;诱发事件数量与90天死亡率显著增加相关。
要点
- 证实的细菌感染和严重酒精性肝炎是肝硬化AD最主要的诱发事件。
- 诱发事件数量越多,90天死亡率越高,且与全身炎症 surrogate 水平升高平行。
- 对证实的细菌感染进行充分一线抗生素治疗与较低ACLF发生率和90天死亡率相关。
核心结论
- 证实的细菌感染、严重酒精性肝炎、伴休克的胃肠道出血和中毒性脑病是与肝硬化急性失代偿持续相关的四类诱发事件。
- 诱发事件类型与死亡率无关,但诱发事件数量与90天死亡率显著增加相关。
研究设计与样本
- 多中心、前瞻性、观察性PREDICT研究(NCT03056612),纳入1,273例非择期住院的肝硬化急性失代偿患者(无ACLF 1,071例,ACLF 202例)。
- 收集入组时及90天随访期间的病史、临床和实验室数据,重点关注诱发事件对器官功能障碍或衰竭的诱导、全身炎症、时间顺序、强度及与结局的关系。
主要发现
- AD-No ACLF队列和AD-ACLF队列中有诱发事件的患者分别占38%和71%。
- 有诱发事件的患者中,几乎全部(分别为96%和97%)存在证实的细菌感染和严重酒精性肝炎,单独或与其他事件联合。
- 两种AD表型中,证实的细菌感染或严重酒精性肝炎患者的生存率相似。
- 诱发事件数量与90天死亡率显著增加相关,并与全身炎症替代标志物水平升高平行。
- 对证实的细菌感染进行充分一线抗生素治疗与较低ACLF发生率和较低90天死亡率相关。
关键数值与推荐
- AD-No ACLF队列中有诱发事件者占38%(原文)。
- AD-ACLF队列中有诱发事件者占71%(原文)。
- 有诱发事件患者中证实的细菌感染和严重酒精性肝炎占比:AD-No ACLF队列96%,AD-ACLF队列97%(原文)。
临床怎么用
- 临床应重视识别肝硬化急性失代偿患者的诱发事件,尤其是证实的细菌感染和严重酒精性肝炎。
- 对证实的细菌感染尽早给予充分一线抗生素治疗,可能降低ACLF发生率和90天死亡率。
- 评估诱发事件数量有助于风险分层,数量越多提示预后越差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Acute decompensation (AD) of cirrhosis may present without acute-on-chronic liver failure (ACLF) (AD-No ACLF), or with ACLF (AD-ACLF), defined by organ failure(s). Herein, we aimed to analyze and characterize the precipitants leading to both of these AD phenotypes. METHODS: The multicenter, prospective, observational PREDICT study (NCT03056612) included 1,273 non-electively hospitalized patients with AD (No ACLF = 1,071; ACLF = 202). Medical history, clinical data and laboratory data were collected at enrolment and during 90-day follow-up, with particular attention given to the following characteristics of precipitants: induction of organ dysfunction or failure, systemic inflammation, chronology, intensity, and relationship to outcome. RESULTS: Among various clinical events, 4 distinct events were precipitants consistently related to AD: proven bacterial infections, severe alcoholic hepatitis, gastrointestinal bleeding with shock and toxic encephalopathy. Among patients with precipitants in the AD-No ACLF cohort and the AD-ACLF cohort (38% and 71%, respectively), almost all (96% and 97%, respectively) showed proven bacterial infection and severe alcoholic hepatitis, either alone or in combination with other events. Survival was similar in patients with proven bacterial infections or severe alcoholic hepatitis in both AD phenotypes. The number of precipitants was associated with significantly increased 90-day mortality and was paralleled by increasing levels of surrogates for systemic inflammation. Importantly, adequate first-line antibiotic treatment of proven bacterial infections was associated with a lower ACLF development rate and lower 90-day mortality. CONCLUSIONS: This study identified precipitants that are significantly associated with a distinct clinical course and prognosis in patients with AD. Specific preventive and therapeutic strategies targeting these events may improve outcomes in patients with decompensated cirrhosis. LAY SUMMARY: Acute decompensation (AD) of cirrhosis is characterized by a rapid deterioration in patient health. Herein, we aimed to analyze the precipitating events that cause AD in patients with cirrhosis. Proven bacterial infections and severe alcoholic hepatitis, either alone or in combination, accounted for almost all (96-97%) cases of AD and acute-on-chronic liver failure. Whilst the type of precipitant was not associated with mortality, the number of precipitant(s) was. This study identified precipitants that are significantly associated with a distinct clinical course and prognosis of patients with AD. Specific preventive and therapeutic strategies targeting these events may improve patient outcomes.
引用
- Trebicka J, Fernandez J, Papp M, et al. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. J Hepatol. 2020. PMID: 33227350. doi:10.1016/j.jhep.2020.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。